International Stem Cell (ISCO) Return on Sales [ROS] (2010 - 2026)
International Stem Cell (ISCO) posted Return on Sales [ROS] of -1.31% for Q2 2026, down 8.13 percentage points from 6.82% a year earlier.
Powered by 
Analysis
International Stem Cell (ISCO) Return on Sales [ROS] (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Return on Sales [ROS] at International Stem Cell was -0.90%, up 0.04 percentage points year-over-year; for FY2025, it came in at -2.93%, down 2.19 percentage points from FY2024.
- Annual Return on Sales [ROS] shows a five-year change of +36.60 percentage points (FY2020 to FY2025).
- In prior years, International Stem Cell's Return on Sales [ROS] was -0.75% in FY2024 (+7.76 pp), -8.51% in FY2023 (-6.27 pp), -2.24% in FY2022 (+24.53 pp) and -26.77% in FY2021 (+12.76 pp).
- Quarterly Return on Sales [ROS] has run from a low of -33.82% in Q3 2021 to a high of 6.82% in Q2 2025 over five years.
- On a year-over-year basis, Return on Sales [ROS] increased in four of the last seven quarters, with an average year-over-year change of +1.05 percentage points.
- The strongest year-over-year quarter for Return on Sales [ROS] in the past five years was Q1 2022, with a gain of 35.44 percentage points; the weakest was Q4 2023, with a drop of 24.96 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,137.66 Bn | 1,106.24 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 636.13 Bn | 556.00 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 505.28 Bn | 478.39 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 358.10 Bn | 312.48 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 292.59 Bn | 256.58 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 265.81 Bn | 239.50 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 237.53 Bn | 192.93 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 171.17 Bn | 117.82 Bn | 10.94 Bn | 28.37% |
| 10 | International Stem Cell | 1.08 Mn | -2.89 Mn | 1.46 Mn | -1.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1.31% |
| Dec 31, 2025 | -14.52% |
| Sep 30, 2025 | 3.97% |
| Jun 30, 2025 | 6.82% |
| Mar 31, 2025 | -10.10% |
| Dec 31, 2024 | 2.09% |
| Sep 30, 2024 | -4.13% |
| Jun 30, 2024 | 6.39% |
| Mar 31, 2024 | -8.36% |
| Dec 31, 2023 | -22.45% |
| Sep 30, 2023 | -4.92% |
| Jun 30, 2023 | -7.82% |
| Mar 31, 2023 | 0.10% |
| Dec 31, 2022 | 2.51% |
| Sep 30, 2022 | -17.62% |
| Jun 30, 2022 | 1.53% |
| Mar 31, 2022 | 1.24% |
| Dec 31, 2021 | -17.53% |
| Sep 30, 2021 | -33.82% |
| Jun 30, 2021 | -22.15% |
API Access
International Stem Cell Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ISCO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "ISCO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=ISCO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();